Butterfly Network Director Dr. Erica Schwartz Resigns After CDC Confirmation

What Happened

• Butterfly Network, Inc. (BFLY) filed a Form 8‑K on August 11, 2026 announcing that Dr. Erica Schwartz has resigned from the Company’s Board of Directors. Her resignation became effective August 5, 2026 upon her confirmation by the U.S. Senate as Director of the Centers for Disease Control and Prevention (CDC). The company said the resignation was not the result of any disagreement with Butterfly on operations, policies, or practices. A press release announcing and congratulating Dr. Schwartz is attached as Exhibit 99.1.

Key Details

• Resignation effective date: August 5, 2026 (upon Senate confirmation as CDC Director).
• Filing date of Form 8‑K: August 11, 2026.
• Company statement: resignation not due to any disagreement with the Company.
• No replacement or other board changes were disclosed in the filing.

Why It Matters

• This is a governance change: investors should note a board seat has become vacant and watch for subsequent announcements about a replacement or board composition updates.
• Dr. Schwartz’s departure removes a director with public‑health expertise, which may be relevant to investor views on the board’s experience mix for a healthcare/medical device company.
• The filing contains no indication of operational or policy disputes, and no immediate financial impact or officer changes were reported.